Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus
about
Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury.Exploration of α1-antitrypsin treatment protocol for islet transplantation: dosing plan and route of administration.Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment.Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.
P2860
Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus
description
im Juni 2015 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2015
@uk
name
Alpha-1 antitrypsin therapy is ...... onset type 1 diabetes mellitus
@en
Alpha-1 antitrypsin therapy is ...... onset type 1 diabetes mellitus
@nl
type
label
Alpha-1 antitrypsin therapy is ...... onset type 1 diabetes mellitus
@en
Alpha-1 antitrypsin therapy is ...... onset type 1 diabetes mellitus
@nl
prefLabel
Alpha-1 antitrypsin therapy is ...... onset type 1 diabetes mellitus
@en
Alpha-1 antitrypsin therapy is ...... onset type 1 diabetes mellitus
@nl
P2093
P2860
P356
P1433
P1476
Alpha-1 antitrypsin therapy is ...... onset type 1 diabetes mellitus
@en
P2093
Eli C Lewis
Hadassa Benzaquen
Michal Ben-Ami
Moshe Phillip
Naomi Weintrob
Nitzan Dror
Orit Horesh
Pnina Strauss
P2860
P304
P356
10.1111/PEDI.12283
P577
2015-06-15T00:00:00Z